Global CAR T-cell Therapy Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CAR T-cell Therapy Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
CAR T-cell Therapy Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CAR T-cell Therapy Drug market is projected to reach US$ 19640 million in 2029, increasing from US$ 2805.8 million in 2022, with the CAGR of 29.9% during the period of 2024 to 2029. Demand from Lymphoma and Multiple Myeloma are the major drivers for the industry.
The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patient's own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CAR T-cell Therapy Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

By Company

Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
Segment by Type
CD19-targeted
BCMA-targeted

Segment by Application

Lymphoma
Multiple Myeloma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CAR T-cell Therapy Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CAR T-cell Therapy Drug introduction, etc. CAR T-cell Therapy Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of CAR T-cell Therapy Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of CAR T-cell Therapy Drug
1.1 CAR T-cell Therapy Drug Market Overview
1.1.1 CAR T-cell Therapy Drug Product Scope
1.1.2 CAR T-cell Therapy Drug Market Status and Outlook
1.2 Global CAR T-cell Therapy Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global CAR T-cell Therapy Drug Market Size by Region (2018-2029)
1.4 Global CAR T-cell Therapy Drug Historic Market Size by Region (2018-2024)
1.5 Global CAR T-cell Therapy Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, CAR T-cell Therapy Drug Market Size (2018-2029)
1.6.1 North America CAR T-cell Therapy Drug Market Size (2018-2029)
1.6.2 Europe CAR T-cell Therapy Drug Market Size (2018-2029)
1.6.3 Asia-Pacific CAR T-cell Therapy Drug Market Size (2018-2029)
1.6.4 Latin America CAR T-cell Therapy Drug Market Size (2018-2029)
1.6.5 Middle East & Africa CAR T-cell Therapy Drug Market Size (2018-2029)
2 CAR T-cell Therapy Drug Market by Type
2.1 Introduction
2.1.1 CD19-targeted
2.1.2 BCMA-targeted
2.2 Global CAR T-cell Therapy Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global CAR T-cell Therapy Drug Historic Market Size by Type (2018-2024)
2.2.2 Global CAR T-cell Therapy Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America CAR T-cell Therapy Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe CAR T-cell Therapy Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific CAR T-cell Therapy Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America CAR T-cell Therapy Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa CAR T-cell Therapy Drug Revenue Breakdown by Type (2018-2029)
3 CAR T-cell Therapy Drug Market Overview by Application
3.1 Introduction
3.1.1 Lymphoma
3.1.2 Multiple Myeloma
3.2 Global CAR T-cell Therapy Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global CAR T-cell Therapy Drug Historic Market Size by Application (2018-2024)
3.2.2 Global CAR T-cell Therapy Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America CAR T-cell Therapy Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe CAR T-cell Therapy Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific CAR T-cell Therapy Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America CAR T-cell Therapy Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa CAR T-cell Therapy Drug Revenue Breakdown by Application (2018-2029)
4 CAR T-cell Therapy Drug Competition Analysis by Players
4.1 Global CAR T-cell Therapy Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CAR T-cell Therapy Drug as of 2022)
4.3 Date of Key Players Enter into CAR T-cell Therapy Drug Market
4.4 Global Top Players CAR T-cell Therapy Drug Headquarters and Area Served
4.5 Key Players CAR T-cell Therapy Drug Product Solution and Service
4.6 Competitive Status
4.6.1 CAR T-cell Therapy Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis CAR T-cell Therapy Drug Products, Services and Solutions
5.1.4 Novartis CAR T-cell Therapy Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Novartis Recent Developments
5.2 Gilead Sciences
5.2.1 Gilead Sciences Profile
5.2.2 Gilead Sciences Main Business
5.2.3 Gilead Sciences CAR T-cell Therapy Drug Products, Services and Solutions
5.2.4 Gilead Sciences CAR T-cell Therapy Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Gilead Sciences Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Products, Services and Solutions
5.3.4 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue (US$ Million) & (2018-2024)
5.3.5 J & J Recent Developments
5.4 J & J
5.4.1 J & J Profile
5.4.2 J & J Main Business
5.4.3 J & J CAR T-cell Therapy Drug Products, Services and Solutions
5.4.4 J & J CAR T-cell Therapy Drug Revenue (US$ Million) & (2018-2024)
5.4.5 J & J Recent Developments
5.5 JW Therapeutics
5.5.1 JW Therapeutics Profile
5.5.2 JW Therapeutics Main Business
5.5.3 JW Therapeutics CAR T-cell Therapy Drug Products, Services and Solutions
5.5.4 JW Therapeutics CAR T-cell Therapy Drug Revenue (US$ Million) & (2018-2024)
5.5.5 JW Therapeutics Recent Developments
5.6 FOSUNKite
5.6.1 FOSUNKite Profile
5.6.2 FOSUNKite Main Business
5.6.3 FOSUNKite CAR T-cell Therapy Drug Products, Services and Solutions
5.6.4 FOSUNKite CAR T-cell Therapy Drug Revenue (US$ Million) & (2018-2024)
5.6.5 FOSUNKite Recent Developments
6 North America
6.1 North America CAR T-cell Therapy Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe CAR T-cell Therapy Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific CAR T-cell Therapy Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America CAR T-cell Therapy Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa CAR T-cell Therapy Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 CAR T-cell Therapy Drug Market Dynamics
11.1 CAR T-cell Therapy Drug Industry Trends
11.2 CAR T-cell Therapy Drug Market Drivers
11.3 CAR T-cell Therapy Drug Market Challenges
11.4 CAR T-cell Therapy Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market CAR T-cell Therapy Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global CAR T-cell Therapy Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global CAR T-cell Therapy Drug Market Size Share by Region (2018-2024)
Table 4. Global CAR T-cell Therapy Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global CAR T-cell Therapy Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global CAR T-cell Therapy Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global CAR T-cell Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global CAR T-cell Therapy Drug Revenue Market Share by Type (2018-2024)
Table 9. Global CAR T-cell Therapy Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global CAR T-cell Therapy Drug Revenue Market Share by Type (2024-2029)
Table 11. North America CAR T-cell Therapy Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America CAR T-cell Therapy Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe CAR T-cell Therapy Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe CAR T-cell Therapy Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific CAR T-cell Therapy Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific CAR T-cell Therapy Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America CAR T-cell Therapy Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America CAR T-cell Therapy Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa CAR T-cell Therapy Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa CAR T-cell Therapy Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global CAR T-cell Therapy Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global CAR T-cell Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global CAR T-cell Therapy Drug Revenue Market Share by Application (2018-2024)
Table 24. Global CAR T-cell Therapy Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global CAR T-cell Therapy Drug Revenue Market Share by Application (2024-2029)
Table 26. North America CAR T-cell Therapy Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America CAR T-cell Therapy Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe CAR T-cell Therapy Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe CAR T-cell Therapy Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific CAR T-cell Therapy Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific CAR T-cell Therapy Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America CAR T-cell Therapy Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America CAR T-cell Therapy Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa CAR T-cell Therapy Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa CAR T-cell Therapy Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global CAR T-cell Therapy Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global CAR T-cell Therapy Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CAR T-cell Therapy Drug as of 2022)
Table 39. Date of Key Players Enter into CAR T-cell Therapy Drug Market
Table 40. Global CAR T-cell Therapy Drug Key Players Headquarters and Area Served
Table 41. CAR T-cell Therapy Drug Product Solution and Service
Table 42. Global CAR T-cell Therapy Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Novartis Basic Information List
Table 45. Novartis Description and Business Overview
Table 46. Novartis CAR T-cell Therapy Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in CAR T-cell Therapy Drug Business of Novartis (2018-2024)
Table 48. Novartis Recent Developments
Table 49. Gilead Sciences Basic Information List
Table 50. Gilead Sciences Description and Business Overview
Table 51. Gilead Sciences CAR T-cell Therapy Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in CAR T-cell Therapy Drug Business of Gilead Sciences (2018-2024)
Table 53. Gilead Sciences Recent Developments
Table 54. Bristol-Myers Squibb Basic Information List
Table 55. Bristol-Myers Squibb Description and Business Overview
Table 56. Bristol-Myers Squibb CAR T-cell Therapy Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in CAR T-cell Therapy Drug Business of Bristol-Myers Squibb (2018-2024)
Table 58. Bristol-Myers Squibb Recent Developments
Table 59. J & J Basic Information List
Table 60. J & J Description and Business Overview
Table 61. J & J CAR T-cell Therapy Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in CAR T-cell Therapy Drug Business of J & J (2018-2024)
Table 63. J & J Recent Developments
Table 64. JW Therapeutics Basic Information List
Table 65. JW Therapeutics Description and Business Overview
Table 66. JW Therapeutics CAR T-cell Therapy Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in CAR T-cell Therapy Drug Business of JW Therapeutics (2018-2024)
Table 68. JW Therapeutics Recent Developments
Table 69. FOSUNKite Basic Information List
Table 70. FOSUNKite Description and Business Overview
Table 71. FOSUNKite CAR T-cell Therapy Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in CAR T-cell Therapy Drug Business of FOSUNKite (2018-2024)
Table 73. FOSUNKite Recent Developments
Table 74. North America CAR T-cell Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 75. North America CAR T-cell Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 76. Europe CAR T-cell Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 77. Europe CAR T-cell Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 78. Asia-Pacific CAR T-cell Therapy Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 79. Asia-Pacific CAR T-cell Therapy Drug Market Size by Region (2018-2024) & (US$ Million)
Table 80. Asia-Pacific CAR T-cell Therapy Drug Market Size by Region (2024-2029) & (US$ Million)
Table 81. Asia-Pacific CAR T-cell Therapy Drug Market Share by Region (2018-2024)
Table 82. Asia-Pacific CAR T-cell Therapy Drug Market Share by Region (2024-2029)
Table 83. Latin America CAR T-cell Therapy Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 84. Latin America CAR T-cell Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 85. Latin America CAR T-cell Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 86. Middle East & Africa CAR T-cell Therapy Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 87. Middle East & Africa CAR T-cell Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 88. Middle East & Africa CAR T-cell Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 89. CAR T-cell Therapy Drug Market Trends
Table 90. CAR T-cell Therapy Drug Market Drivers
Table 91. CAR T-cell Therapy Drug Market Challenges
Table 92. CAR T-cell Therapy Drug Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-cell Therapy Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global CAR T-cell Therapy Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global CAR T-cell Therapy Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global CAR T-cell Therapy Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America CAR T-cell Therapy Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe CAR T-cell Therapy Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific CAR T-cell Therapy Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America CAR T-cell Therapy Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa CAR T-cell Therapy Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of CD19-targeted
Figure 11. Global CD19-targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of BCMA-targeted
Figure 13. Global BCMA-targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global CAR T-cell Therapy Drug Market Size Share by Type: 2022 & 2029
Figure 15. North America CAR T-cell Therapy Drug Revenue Market Share by Type (2018-2029)
Figure 16. Europe CAR T-cell Therapy Drug Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific CAR T-cell Therapy Drug Revenue Market Share by Type (2018-2029)
Figure 18. Latin America CAR T-cell Therapy Drug Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa CAR T-cell Therapy Drug Revenue Market Share by Type (2018-2029)
Figure 20. Lymphoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Multiple Myeloma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Global CAR T-cell Therapy Drug Market Size Share by Application: 2022 & 2029
Figure 23. North America CAR T-cell Therapy Drug Revenue Market Share by Application (2018-2029)
Figure 24. Europe CAR T-cell Therapy Drug Revenue Market Share by Application (2018-2029)
Figure 25. Asia-Pacific CAR T-cell Therapy Drug Revenue Market Share by Application (2018-2029)
Figure 26. Latin America CAR T-cell Therapy Drug Revenue Market Share by Application (2018-2029)
Figure 27. Middle East and Africa CAR T-cell Therapy Drug Revenue Market Share by Application (2018-2029)
Figure 28. CAR T-cell Therapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players CAR T-cell Therapy Drug Market Share in 2022
Figure 30. North America CAR T-cell Therapy Drug Market Share by Country (2018-2029)
Figure 31. United States CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 32. Canada CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 33. Germany CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 34. France CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 35. U.K. CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 36. Italy CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 37. Russia CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 38. Nordic Countries CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific CAR T-cell Therapy Drug Market Share by Region (2018-2029)
Figure 40. China CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 41. Japan CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 42. South Korea CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 43. Southeast Asia CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 44. India CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 45. Australia CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 46. Latin America CAR T-cell Therapy Drug Market Share by Country (2018-2029)
Figure 47. Mexico CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 48. Brazil CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa CAR T-cell Therapy Drug Market Share by Country (2018-2029)
Figure 50. Turkey CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 52. UAE CAR T-cell Therapy Drug Market Size (2018-2029) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report

Global CAR T-cell Therapy Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Global CAR T-cell Therapy Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

By Company

Segment by Application

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries